Sayed Sabek, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1050 N Cherry St, Tulare Va Clinic, Tulare, CA 93274 Phone: 559-684-8703 Fax: 559-248-5329 |
Dr. Ronald A. Smith, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 869 North Cherry Street, Tulare, CA 93274 Phone: 559-685-3450 Fax: 559-685-3869 |
Dr. Harold Michael Boulton, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 869 N Cherry St, Tulare, CA 93274 Phone: 559-605-0310 Fax: 559-605-0312 |
Dr. Ronald Joseph Ostrom, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 869 N Cherry St, Tulare, CA 93274 Phone: 559-688-0821 |
News Archive
New optical imaging technology developed at Tufts University School of Engineering could give doctors new ways to both identify breast cancer and monitor individual patients' response to initial treatment of the disease.
Venous thromboembolism (VTE) is the third most common type of cardiovascular disease after coronary heart disease and stroke. Researchers at the Centre for Primary Health Care Research in Malmö have mapped the significance of hereditary factors for venous thromboembolism in the entire Swedish population by studying the risk of VTE in children of parents with VTE compared with the children of parents who have not had VTE.
In a study appearing in the May 3, 2016 issue of JAMA, Anette-Gabriele Ziegler, M.D., of Helmholtz Zentrum Munchen, Munich, Germany, and colleagues examined associations between infection types during the first 2 years of life and between respiratory tract infections in the first 6 months and type l diabetes (T1D). Viral infections, particularly enteroviruses, have been hypothesized to cause T1D. Recent studies suggest that respiratory tract infections are associated with increased T1D risk if they are encountered within the first 6 months.
In a breakthrough that could lead to new treatments for patients with malignant melanoma, researchers from Mount Sinai School of Medicine have discovered that a particular protein suppresses the progression of melanoma through regulation of an oncogene, or gene responsible for cancer growth. The study is published in the December 23 issue of Nature.
› Verified 2 days ago